Archives of Cardiovascular Diseases Supplements最新文献

筛选
英文 中文
Percutaneous closure of the inter-auricular communications of the child: About 24 cases 经皮小儿耳间交通封闭术:约24例
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.049
G. Bennani, B.E.N.N.A. Amri
{"title":"Percutaneous closure of the inter-auricular communications of the child: About 24 cases","authors":"G. Bennani,&nbsp;B.E.N.N.A. Amri","doi":"10.1016/j.acvdsp.2023.07.049","DOIUrl":"10.1016/j.acvdsp.2023.07.049","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Percutaneous closure by interventional catheterization of </span>atrial septal defect<span> is currently considered to be the technique of first-choice closure subject to meeting the recommended criteria, anatomical and hemodynamic.</span></p></div><div><h3>Objective</h3><p>The objective of this work is to assess the effectiveness and safety of this technique.</p></div><div><h3>Methods</h3><p>Our retrospective study is carried out in the cardiology department of Ibn Rochd hospital, including 24 patients who benefit from percutaneous closure by catheterization intervention of their CIA.</p></div><div><h3>Results/Expected results</h3><p>Our series notes a female predominance (17 F and 7 M), the average age at the time of the intervention was 7 years (3 years is 17), the average weight is 27 kg (10–80<!--> <span>kg), the discovery of a heart murmur and pneumonia has repetitions are the 2 most frequent reasons for consultation. The TTE is the key examination that allowed the diagnosis positive of the CIA, to define its denials, the signs of repercussion and especially to establish with precision the anatomical edges of the defect and establish the indication for closure by interventional catheterization.</span></p><p><span>Transesophageal and transthoracic doppler echocardiography are a useful complement during the intervention which was of great help for the success of the installation of the prosthesis. The choice of the prosthesis is made according to the size of the CIA. All our patients are followed, their clinical examination finds a good evolution with improvement of the functional signs and good weight gain. </span>Echocardiography is satisfactory (prosthesis in place and absence of shunt) in 23 cases of CIA or 95.8%, and showed a minimal residual shunt in only 1 case or 4.1%. No late complications are occurred over a 36-month follow-up.</p></div><div><h3>Conclusion/Perspectives</h3><p>Percutaneous closure of CIA is a safe and effective method; the selection of candidate patients is essential according to the type of CIA and its anatomy...</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page 295"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44931016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and consequences of mitral annular disjunction and Pickelhaude sign in children with mitral valve prolapse 二尖瓣脱垂儿童二尖瓣环分离和皮克尔haude征的患病率及后果
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.009
G. Vaksmann, I. Bouzguenda, M.P. Guillaume, P. Gras, A. Richard
{"title":"Prevalence and consequences of mitral annular disjunction and Pickelhaude sign in children with mitral valve prolapse","authors":"G. Vaksmann,&nbsp;I. Bouzguenda,&nbsp;M.P. Guillaume,&nbsp;P. Gras,&nbsp;A. Richard","doi":"10.1016/j.acvdsp.2023.07.009","DOIUrl":"10.1016/j.acvdsp.2023.07.009","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Mitral annulus<span><span> disjunction (MAD) and Pickelhaube sign are increasingly identified as risk factors for malignant ventricular arrhythmias (VAs) and </span>sudden cardiac death in adults with </span></span>mitral valve prolapse (MVP). Their prevalence and consequences in children have never been studied.</p></div><div><h3>Objective</h3><p>To determine MAD prevalence in children with MVP and its potential link with Vas.</p></div><div><h3>Methods</h3><p>A cohort of 49 consecutive children from a single institution (age 12.8<!--> <!-->±<!--> <span><span>3.0, 33 females) with MVP and comprehensive clinical, arrhythmia (24-h Holter monitoring and exercise test) and doppler echocardiographic characterization including pulsed wave </span>tissue doppler (PWTD) of the lateral mitral annulus was identified. The relationship between clinical and echocardiographic data and the presence of VAs was studied.</span></p></div><div><h3>Results/Expected results</h3><p>The presence of MAD was common (<em>n</em> <!-->=<!--> <!-->25, 51%). Only 5 patients had significant VAs (lown<!--> <!-->&gt;<!--> <span>2) characterized by polymorphic premature ventricular contractions or couplets. The presence of MAD was not associated with significant VAs on 24h-Holter monitoring but an association was found between significant VAs and spiked high velocity midsystolic signal</span> <!-->&gt;<!--> <!-->16<!--> <!-->cm/s on PWTD of the lateral mitral annulus (Pickelhaube sign, <span>Figure 1</span>) (<em>P</em> <!-->=<!--> <!-->0.004), myxomatous mitral valve (<em>P</em> <!-->=<!--> <!-->0.004) and left ventricular dilatation (<em>P</em> <!-->=<!--> <span><span><span>0.01). No patient had severe VAs characterized by ventricular tachycardia<span> nor symptoms of dysrhythmia. Four out of 7 patients (57%) with coexisting Pickelhaube sign and myxomatous mitral valve had significant VAs. No difference was found between patients with or without MAD for gender, history of palpitation, severity of </span></span>mitral regurgitation, incidence of </span>connective tissue disorders<span> and medications with beta-blockers or ACE inhibitors.</span></span></p></div><div><h3>Conclusion/Perspectives</h3><p>MAD is a common finding in children with MVP. Its presence was not associated with significant VAs on 24-hour Holter monitoring, but the Pickelhaube sign and the presence of myxomatous mitral valve may help to detect patients prone to significant VAs.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page 277"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48490643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ours FCPC 熊FCPC
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/S1878-6480(23)00279-3
{"title":"Ours FCPC","authors":"","doi":"10.1016/S1878-6480(23)00279-3","DOIUrl":"10.1016/S1878-6480(23)00279-3","url":null,"abstract":"","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page iii"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42709585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregrancy in Fontan patients: Should we refine the current recommendations? Fontan患者的妊娠:我们应该改进目前的建议吗?
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.005
M. Ladouceur , G. Gennesseaux , V. Gruschen , Pregnancy Outcomes In Fontans With Anticoagulation Therapy (profit) Inverstigator
{"title":"Pregrancy in Fontan patients: Should we refine the current recommendations?","authors":"M. Ladouceur ,&nbsp;G. Gennesseaux ,&nbsp;V. Gruschen ,&nbsp;Pregnancy Outcomes In Fontans With Anticoagulation Therapy (profit) Inverstigator","doi":"10.1016/j.acvdsp.2023.07.005","DOIUrl":"10.1016/j.acvdsp.2023.07.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Pregnancies in patients with a Fontan circulation are high-to very high-risk pregnancies. European and American recommendations consider patients with any Fontan complications should be counseled against becoming pregnant.</p></div><div><h3>Objective</h3><p>This study sought to evaluate maternal complications in patients with Fontan circulation according to the modified WHO (mWHO) classification.</p></div><div><h3>Methods</h3><p><span>We performed a retrospective observational cohort study across 13 international centers. Maternal and fetal outcomes were reviewed according to baseline risk assessed as per the mWHO classification. Women with oxygen saturations &lt;</span> <span>85%, NYHA<span><span> functional class IV, depressed ventricular function, moderate to severe atrioventricular valve regurgitation, refractory arrhythmia, plastic </span>bronchitis, or protein-losing enteropathy (PLE) were considered at very high risk of complications (mWHO IV), those without any Fontan complication were classified at high risk (mWHO III). The risk of remaining patients who experienced other types of Fontan complications was classified as mWHO III–IV.</span></span></p></div><div><h3>Results/Expected results</h3><p>We analyzed 84 women (median age 27 years, interquartile range 23-30) with Fontan physiology undergoing 108 complete pregnancies, average gestation of 33<!--> <!-->±<!--> <!-->5 weeks. Fifty-two (48%) pregnancies were classified as mWHO III, 45 (42%) mWHO III–IV, and 11 (10%) mWHO IV (<span>Table 1</span>). None patients had a previous history of PLE or plastic bronchitis. There was no maternal death. Cardiovascular complications occurred in 13 (25%), 16 (35%) and 4 (36%) pregnancies classified mWHO III, III–IV, and IV respectively (<em>P</em> <!-->=<!--> <!-->0.74). Cardiovascular complication rates remained not significantly different when patients with any Fontan complications were compared to patients without (36% vs. 25%, <em>P</em> <!-->=<!--> <!-->0.23; <span>Table 1</span>). There were high rates of fetal (<em>n</em> <!-->=<!--> <!-->73, 68%) and obstetrical (<em>n</em> <!-->=<!--> <!-->75, 69% including 38 bleeding events) complications without significant difference between the 3 risk groups.</p></div><div><h3>Conclusion/Perspectives</h3><p>Maternal cardiovascular complications occurred in one-third of pregnancies whatever the mWHO classification. Even if there is no reported maternal death, women with Fontan circulation should be carefully counseled on pregnancy risks.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 274-275"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49217829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute, intermediate and long-term complications after aortic coarctation stenting 主动脉缩窄支架置入术后的急性、中期和长期并发症
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.022
M. Albertini , R. Haddad , M. Mostefa-Kara , A.S. Chaussade , M. Ladouceur , L. Iserin , D. Bonnet , S. Malekzadeh-Milani
{"title":"Acute, intermediate and long-term complications after aortic coarctation stenting","authors":"M. Albertini ,&nbsp;R. Haddad ,&nbsp;M. Mostefa-Kara ,&nbsp;A.S. Chaussade ,&nbsp;M. Ladouceur ,&nbsp;L. Iserin ,&nbsp;D. Bonnet ,&nbsp;S. Malekzadeh-Milani","doi":"10.1016/j.acvdsp.2023.07.022","DOIUrl":"10.1016/j.acvdsp.2023.07.022","url":null,"abstract":"<div><h3>Introduction</h3><p><span>In native aortic coarctation, as well as recoarctation with appropriate </span>anatomy<span>, stenting has become the treatment of first choice according to European guidelines.</span></p></div><div><h3>Objective</h3><p>The objective of this study was to assess the safety as well as the short and long-term efficacy of percutaneous treatment of aortic coarctation/recoarctation in adults.</p></div><div><h3>Methods</h3><p>This study included all adult patients with a native or post-operative aortic coarctation treated percutaneously in a single center from March 2006 to December 2022. Baseline characteristics, intra-procedural and follow-up data were analyzed. The primary outcome was acute procedural success and secondary outcomes were intra-operative and late complications.</p></div><div><h3>Results/Expected results</h3><p><span>A total of 62 patients were included. The mean age was 35 years (range, 15–74), 33 (53.2%) patients were male. Thirty patients (48.3%) had a native aortic coarctation, 57 (91.9%) were hypertensive and 32 (51.6%) had a bicuspid aortic valve. Acute procedural success was achieved in all patients with a peak-to-peak gradient at the end of the procedure lower than 20</span> <span>mmHg in 60 (96.7%) patients. Two (3.2%) patients had a non-fatal aortic rupture<span><span> without sequelae and 2 (3.2%) had a false femoral aneurysm requiring intervention. At the follow-up visit, 55.3% patients had persistent arterial hypertension requiring medical treatment. Regarding late complications, 3 (4,8%) patients had aortic recoarctation that required a new percutaneous procedure, 1 (1,6%) patient had a type B </span>aortic dissection<span> that did not require invasive management, and 1 (1,6%) patient had a thrombosis of the right external iliac artery.</span></span></span></p></div><div><h3>Conclusion/Perspectives</h3><p>Percutaneous treatment with stenting of aortic coarctations in adults is safe and effective when performed in expert centers. Follow-up of this cohort will bring important data on very long-term outcomes associated with this technique.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page 283"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46492722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery of abnormal features of the infrahepatic portion of the inferior vena cava during a mitral percutaneous balloon commissurotomy 二尖瓣经皮球囊连合切开术中发现下腔静脉肝下部分异常
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.050
R. Kchaou, H. Boukhil, E.H. Samia
{"title":"Discovery of abnormal features of the infrahepatic portion of the inferior vena cava during a mitral percutaneous balloon commissurotomy","authors":"R. Kchaou,&nbsp;H. Boukhil,&nbsp;E.H. Samia","doi":"10.1016/j.acvdsp.2023.07.050","DOIUrl":"10.1016/j.acvdsp.2023.07.050","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Infrahepatic interruption of the inferior vena cava (IVC) with </span>azygos or hemiazygos continuation is a rare finding.</p><p><span>In this anatomic entity, the intrahepatic segment of the IVC is absent, and the hepatic veins<span> empty directly into the right atrium. </span></span>Venous blood flow<span> from the lower body is directed from the IVC into the azygos system at the level of the renal veins<span>, with resultant dilation of the azygos and/or hemiazygos veins.</span></span></p></div><div><h3>Objective</h3><p><span>We report the case of azygos continuation of the IVC. The diagnosis was made during a catheterization during a Percutaneous Transluminal </span>Mitral Commissurotomy.</p><p>A 56 years old female, with the history of diabetes mellitus, blood hypertension, hypothyroidism, and a mitral valve stenosis<span> of rheumatic origin dilated 20 years ago, presented with dyspnea NYHA<span> II. The clinical findings were: a low-pitched diastolic murmur, no sign of right cardiac failure.</span></span></p><p><span>Transthoracic echocardiography Show a mitrale surface in 1,3 cm</span><sup>2</sup>. During the procedure of mitral diltation it was impossible to cross the IVC. We performed an Aortic CT-SCAN revealing aninfrahepatic interruption of the inferior vena cava (IVC) with azygos continuation.</p></div><div><h3>Conclusion/Perspectives</h3><p>Anomalous inferior vena cava with azygos or hemiazygos continuation is best interpreted as interruption or failure of fusion of the hepatic and prerenal segments of the inferior vena cava, combined with persistence of either the right lumbar azygos vein or left lumbar hemiazygos vein. Thus, a better term for the anomaly would be infrahepatic interruption of the inferior vena cava with azygos (hemiazygos) continuation.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 295-296"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49062120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous edge-to-edge repair of systemic tricuspid regurgitation in adults with congenital heart disease 经皮边缘对边缘修复成人先天性心脏病全身三尖瓣反流
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.010
L. Le Gloan , X. Iriart , H. Bouvaist , Y. Lavie-Badie , E. Hereau , P. Guérin
{"title":"Percutaneous edge-to-edge repair of systemic tricuspid regurgitation in adults with congenital heart disease","authors":"L. Le Gloan ,&nbsp;X. Iriart ,&nbsp;H. Bouvaist ,&nbsp;Y. Lavie-Badie ,&nbsp;E. Hereau ,&nbsp;P. Guérin","doi":"10.1016/j.acvdsp.2023.07.010","DOIUrl":"10.1016/j.acvdsp.2023.07.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Systemic tricuspid valve regurgitation<span><span> (TR) is often encountered in patients with atrial correction of transposition of the </span>great arteries<span> (acTGA) or congenitally corrected transposition of the great arteries (ccTGA). When at least moderate, it is related to impaired functional capacity, heart failure and mortality. Management is a matter of debate as medical management is limited and valvular surgery at risk. Among adults with severe and symptomatic systemic mitral regurgitation at high risk for surgery, percutaneous edge-to-edge repair is now proposed as a reasonable alternative.</span></span></p></div><div><h3>Methods</h3><p>We hypothetised that percutaneous management of systemic TR may be feasible and safe. A monthly national dedicated multidisciplinary meeting was therefore organized, including cardiologists and surgeons dedicated to adults with CHD. All concerned patients were evaluated and a decision was taken and thereafter offered to each patients.</p></div><div><h3>Results/Expected results</h3><p>So far, 9 patients, of whom 1 female, with a median age of 41<!--> <!-->±<!--> <span><span><span>14 years, were included, 4 with acTGA and 5 with ccTGA. The procedures were performed in 4 French tertiary CHD centers between May 2019 and June 2022, following institutional review board approval. The XTR MitraClip device (Abbott, Santa Clara, CA) was used, 1 MitraClip was used in 5 patients, 2 in 2 and 3 in 1. The procedure was not possible in 1 patient, because of impossibility to achieve appropriate orientation of the clip on the tricuspid valve. No complication was reported. At 6 months of follow-up, we noticed a decrease in the TR of at least 1 grade in 8 patients. </span>NYHA functional class improved in 5 patients and </span>diuretics doses decreased in 4.</span></p></div><div><h3>Conclusion/Perspectives</h3><p>Transcatheter edge-to-edge repair appears as a feasible and safe procedure in patients with significant systemic TR. Further studies need to be performed to precise the optimal position of percutaneous reduction of systemic TR in the management of these patients.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 277-278"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44553202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Report postoperative pediatric cardiac surgery? Review and analysis of the literature 小儿心脏手术后如何报告?文献回顾与分析
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.020
V. Bois, D. Ramlugun, J. Bordet, C. Olexa, P. Billaud, L. Bonnemains
{"title":"How to Report postoperative pediatric cardiac surgery? Review and analysis of the literature","authors":"V. Bois,&nbsp;D. Ramlugun,&nbsp;J. Bordet,&nbsp;C. Olexa,&nbsp;P. Billaud,&nbsp;L. Bonnemains","doi":"10.1016/j.acvdsp.2023.07.020","DOIUrl":"10.1016/j.acvdsp.2023.07.020","url":null,"abstract":"<div><h3>Introduction</h3><p>Since the disqualification of mortality as unique quality outcome after pediatric cardiac surgery, many quality outcomes have been proposed without any universal agreement.</p></div><div><h3>Objective</h3><p>To list the most used quality outcomes from a literature review and to analyze the behavior of these quality outcomes.</p></div><div><h3>Methods</h3><p>The study was restricted to Arterial Switch Operation<span> (ASO) and Ventricular Septal Defects Closure (VSDC). Three criteria were used to qualify the quality outcomes: variation in time, variation between centers, and dependency on surgical severity. The analysis was performed using data extracted from an extensive review of the literature and from our local database. The categorial outcomes were automaticaly classified by a grouping algorithm. All the outcomes significantly described in the litterature were clustered. Programmation was performed in R.</span></p></div><div><h3>Results/Expected results</h3><p>The literature review identified 41 articles discussing quality outcomes of pediatric cardiac surgery. 18 quality outcomes were extracted. In total, 15 centers were found to have reported surgery early outcomes (nine for ASO and six for VSDC). The outcomes clusterisation is presented in <span>Figure 1</span>.</p></div><div><h3>Conclusion/Perspectives</h3><p>Three groups of outcomes were identified: 1/ Medical Hazards (mortality, resuscitation, extra corporeal membrane oxygenation, neurological events, atrio-ventricular block), 2/Expected events and preventive strategies (renal support, effusion, delayed sternal closure, length of stays, durations of amine/ventilation) and 3/ unwanted adverse events (reintervention/readmission, infectious event, reintubation). This list of outcomes could be used as a standard base for future reports.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 282-283"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41347750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective review of M3C-Necker experience with transcatheter management of coronary artery fistulas M3C-Necker经导管治疗冠状动脉瘘的经验回顾
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.037
R. Haddad, D. Bonnet, S. Malekzadeh-Milani
{"title":"Retrospective review of M3C-Necker experience with transcatheter management of coronary artery fistulas","authors":"R. Haddad,&nbsp;D. Bonnet,&nbsp;S. Malekzadeh-Milani","doi":"10.1016/j.acvdsp.2023.07.037","DOIUrl":"10.1016/j.acvdsp.2023.07.037","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Coronary artery fistulas (CAFs) are rare </span>coronary anomalies and transcatheter closure remains debatable.</p></div><div><h3>Objective</h3><p>To evaluate our experience with transcatheter management of CAFs.</p></div><div><h3>Methods</h3><p>Retrospective clinical data review of all children in whom echocardiographically suspected CAFs were confirmed during cardiac catheterization from 2000 to 2022.</p></div><div><h3>Results/Expected results</h3><p><span><span>In total, 92 CAFs were identified in 76 patients (44% males) with a median age of 3.8 years (IQR, 0.8–7). 25 (32.9%) patients had concomitant congenital anomalies<span> and 9 (11.8%) had coronary artery anomalies. 39/51 (76.5%) patients with isolated CAFs were asymptomatic at diagnosis. 27 (35.5%) patients had pre-procedural CT angiography. CAFs mainly originated from the </span></span>left main coronary artery (42.4%) and </span>right coronary artery<span> (38.1%). Drainage sites were mainly the right cavities (80.4%). 23/76 (30.3%) patients with 35/92 (38%) small CAFs had no intervention with a benign clinical long-term follow-up. 8/76 (10.5%) patients with 9/92 (9.8%) CAFs not amenable to percutaneous closure were directly sent for surgery. 45/76 (59.2%) patients had percutaneous closure of 48/92 (52.2%) CAFs using microcoils (31.3%), device occluders (58.3%), or both (10.4%). Occlusion material was exchanged before release in 4 (8.9%) patients. Devices were deployed transvenously using a track wire loop in 19/48 (39.6%) CAFs. Closure approach was modified per-operatively in 4 (8.9%) patients. Percutaneous closure was unsuccessful in 3 (6.7%) patients of which 2 had surgical ligation. Twelve complications occurred including 7 transient ST–T wave changes, 2 asymptomatic coronary pseudo-stenosis, one coronary dissection, and one pulmonary edema. Repeat closure was needed in 3 (6.7%) patients for residual leak and was unsuccessful in 2 of them. One patient had trivial CAF recanalization with an asymptomatic 12-year follow-up.</span></p></div><div><h3>Conclusion/Perspectives</h3><p>Transcatheter closure of CAFs is feasible and effective in carefully selected patients. Complications are frequent but not permanent. Surgery is a valuable upfront option in large and technically complex CAFs or a bailout of failed percutaneous attempts.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page 290"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48986623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does simulation-based training improve the involvement of cardiology health professionals during pediatric cardiac arrest? 基于模拟的培训是否能提高儿科心脏骤停期间心脏病学健康专业人员的参与度?
IF 18
Archives of Cardiovascular Diseases Supplements Pub Date : 2023-09-01 Epub Date: 2023-09-07 DOI: 10.1016/j.acvdsp.2023.07.027
A. Fernando , G. Pettersen , A. Levy , L. Mazine , M. Ahmed
{"title":"Does simulation-based training improve the involvement of cardiology health professionals during pediatric cardiac arrest?","authors":"A. Fernando ,&nbsp;G. Pettersen ,&nbsp;A. Levy ,&nbsp;L. Mazine ,&nbsp;M. Ahmed","doi":"10.1016/j.acvdsp.2023.07.027","DOIUrl":"10.1016/j.acvdsp.2023.07.027","url":null,"abstract":"<div><h3>Introduction</h3><p>Healthcare professionals working in a pediatric cardiology department (PCD) could be exposed to a cardiac arrest (CA).</p><p>The expertise required for the interprofessional management of a CA could be achieved through in situ simulation.</p><p>The lack of a simulation culture within the department hinders the development of a simulation-based teaching program.</p></div><div><h3>Objective</h3><p><span>Does an educational session composed of a simulation-based bootcamp followed by an in situ simulation focused on the management of a shockable pediatric CA lead the intention of modifying behaviours among health professionals in the PCD? The primary objective is to assess the intention that pediatric cardiology healthcare professionals have in modifying their involvement when managing pediatric CA, following an educational simulation session. The secondary objective is to identify latent safety threats (LSTs) in the current </span>work environment during the in situ simulation sessions.</p></div><div><h3>Methods</h3><p>Members of the pediatric cardiology department participated in an educational session (bootcamp and an in situ simulation session).</p><p>The educational session focused on the multidisciplinary management of a shockable cardiac arrest until the arrival of the code blue team.</p><p>Intention to modify behaviors was documented using the REACTION questionnaire (<span>Figure 1</span>). Simulations and debriefings were be video-recorded and reviewed to identify LSTs in the current workplace.</p></div><div><h3>Results/Expected results</h3><p>After participating in the educational simulation session, participants have a clear intention in modifying their involvement when managing pediatric CA (initiation and participation)</p><p>The simulation sessions identified moderate and severe LSTs. A serious problem of calling for help in the department was identified.</p></div><div><h3>Conclusion/Perspectives</h3><p>The educational session consisting of a simulation-based bootcamp followed by an in situ simulation focused on the management of CA led to the intention of changing the behaviors of healthcare professionals in the PDC.</p><p>Almost the entire department is now introduced to simulation, and we observe culture change is underway.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 285-286"},"PeriodicalIF":18.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49631709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书